Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/2005
06/22/2005CN1207039C Medicine for treating cerebral concussion and injuries from falls
06/22/2005CN1207035C Chinese medicinal vinegar pills for treating heart disease, wind damp disease and cerebrovascular disease
06/22/2005CN1207024C Chinese medicine composite for treating gouty arthropathy
06/22/2005CN1207022C Medicinal composition for promoting bone-fracture healing and bone-joint injure repairing
06/21/2005US6909007 Steroidal pharmaceutical compounds
06/21/2005US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues
06/21/2005US6908935 Calcium receptor modulating agents
06/21/2005US6908930 4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors
06/21/2005US6908920 Pyrimidine derivatives
06/21/2005US6908917 Chromone derivatives as matrix metalloproteinase inhibitors
06/21/2005CA2250372C 6-phenylpyridyl-2-amine derivatives
06/17/2005CA2479432A1 Thiazole derivatives
06/16/2005WO2005054249A1 Novel compounds
06/16/2005WO2005054213A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor
06/16/2005WO2005053718A1 Methods and compositions for treating inflammatory and dermatological conditions
06/16/2005WO2005053661A2 Pharmaceutical combinations
06/16/2005WO2004048565A9 Apoptosis-associated protein and use thereof
06/16/2005US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
06/16/2005US20050131048 Enhancement of bone growth and inhibition of bone resorption
06/16/2005US20050131047 cardiovascular disorders
06/16/2005US20050131035 Medicaments
06/16/2005US20050131024 Antiinflammatory agents; autoimmune diseases; anticancer agents
06/16/2005US20050131005 4-azasteroid derivatives as androgen receptor modulators
06/16/2005US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
06/16/2005US20050130999 Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins
06/16/2005US20050130998 Central nervous ystem diorders; Alzheimer's disease ; anticancer agents
06/16/2005US20050130981 Compounds
06/16/2005US20050130965 Inhibitors of p38 kinase
06/16/2005US20050130964 e.g 8-oxa-1-thia-benzo[e]naphtho[3,2-h]azulene-2-carboxylic acid ethyl ester; rheumatoid arthritis
06/16/2005US20050130942 (E)-2,4,6-trimethoxystyryl-4-methoxy-3-aminobenzylsulfone for example; cancer, tumors, multiple sclerosis, Pagets disease; antibody conjugates; target receptor tyrosine kinases and which arrest the Ras/Raf/MEK/ERK kinase cascade
06/16/2005US20050130935 Combination of a beta-2-adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
06/16/2005US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
06/16/2005US20050130902 Upregulate expression of a gene encoding an antioxidative anzyme, such as superoxide dismutase or catalase; neurodegenerative, cardiovascular, cerebral, disorders, trauma, injuries, burns, cancer
06/16/2005US20050130887 Method of diagnosis and detection of potential carriers of mutated gene, bone related diseases; gene therapy recombinant technology and therapy using information derived from the DNA, protein and the function of the protein
06/16/2005US20050130881 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
06/16/2005US20050130304 Regulation of endogenous gene expression in cells using zinc finger proteins
06/16/2005US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening
06/16/2005US20050129786 Topical composition having undifferentiated plant seed cells and method for using same
06/16/2005US20050129657 Interferon-alpha induced gene
06/16/2005DE202005005557U1 Oil or balm for treating rheumatism, gout, sciatica, joint pain and back pain comprises a St John's wort extract, an arnica extract and essential oils
06/16/2005DE19916419B4 Kombinationspräparat aus Vitamin-D-Metaboliten oder Vitamin-D-Analoga und einem Östrogenpartialagonisten zur Behandlung von Osteoporose Combination preparation of vitamin D metabolites or vitamin D analogs and a Östrogenpartialagonisten for the treatment of osteoporosis
06/16/2005CA2547887A1 Protein modifier production inhibitor
06/16/2005CA2547651A1 Anti-inflammatory agents
06/16/2005CA2546738A1 Pharmaceutical combinations
06/16/2005CA2546710A1 Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
06/16/2005CA2546649A1 Treatment of rheumatoid arthritis with hypoxia-inducible factor 1.alpha. antagonists
06/16/2005CA2546111A1 Biomarkers for the efficacy of calcitonin and parathyroid hormone treatment
06/15/2005EP1541585A1 Cxcr4 antagonist and use thereof
06/15/2005EP1541583A1 Non-t cell binding peptides and their uses
06/15/2005EP1541576A1 Furoisoquinoline derivative and use thereof
06/15/2005EP1541574A1 Triazaspiro 5.5 undecane derivatives and drugs comprisi ng the same as the active ingredient
06/15/2005EP1541573A1 Novel crystals of triazaspiro 5.5 undecane derivative
06/15/2005EP1541571A1 Bicyclic unsaturated tertiary amine compound
06/15/2005EP1541570A1 Novel physiologically active substance
06/15/2005EP1541563A1 Ccr4 antagonist and medicinal use thereof
06/15/2005EP1541560A1 Novel tetrahydroquinoline derivatives
06/15/2005EP1541149A1 Phosphodiesterase inhibitor
06/15/2005EP1539933A2 Methods of organ regeneration
06/15/2005EP1539769A1 Bicyclic heteroaromatic compounds as kinase inhibitors
06/15/2005EP1539763A1 Azaindole kinase inhibitors
06/15/2005EP1539748A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
06/15/2005EP1539741A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
06/15/2005EP1539739A1 Piperidinyl compounds that selectively bind integrins
06/15/2005EP1539732A1 Novel compounds
06/15/2005EP1539713A1 Pyrimidine derivatives as modulators of chemokine receptor activity
06/15/2005EP1539701A1 Caspase inhibitors and uses thereof
06/15/2005EP1539696A2 Process for preparing quinolin antibiotic intermediates
06/15/2005EP1539695A1 N-4-piperidinyl compounds as ccr5 modulators
06/15/2005EP1539693A1 Cannabinoid receptor agonists
06/15/2005EP1539687A1 Substituted glycine derivatives for use as medicaments
06/15/2005EP1539685A1 Mcp-1 receptor antagonists and method of use thereof
06/15/2005EP1539683A2 Phenol derivatives and their use as rotamase inhibitors
06/15/2005EP1539679A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
06/15/2005EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands
06/15/2005EP1539674A1 Amino-propanol derivatives
06/15/2005EP1539662A1 Cannabinoid receptor ligands
06/15/2005EP1539227A2 Papaine containing pharmaceutical formulation resp. its use
06/15/2005EP1539185A2 Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates (no-bisphosphonate)
06/15/2005EP1539179A2 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof
06/15/2005EP1539176A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
06/15/2005EP1539143A2 Leflunomide analogs for treating rheumatoid arthritis
06/15/2005EP1539121A2 Methods of promoting osteogenesis
06/15/2005EP1538927A1 Fruit and/or vegetable derived composition
06/15/2005EP1439831B1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
06/15/2005EP1372669B1 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
06/15/2005EP1351680B1 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
06/15/2005EP1345609B1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists
06/15/2005EP1325007B1 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
06/15/2005EP1278740B1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
06/15/2005EP1248785B1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
06/15/2005EP1244625B1 4-pyridinyl-n-acyl-l-phenylalanines
06/15/2005EP1104412B1 Tace inhibitors
06/15/2005EP1064277B1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
06/15/2005EP1005359B1 FRACTURE HEALING USING PTHrP ANALOGS
06/15/2005EP1001979B1 Cyclic azapeptides with angiogenic effect
06/15/2005EP0994704B1 Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
06/15/2005EP0979099B1 Use of lactoferin in the treatment of allergen induced disorders
06/15/2005CN1628128A Mammal prolactin variants
06/15/2005CN1628116A Inhibitors of alpha l beta 2 integrin mediated cell adhesion
06/15/2005CN1628103A Pyrimidine derivitive
1 ... 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 ... 820